This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase risk of adverse events.
Fabry disease;
Age ≥ 18 years.
History of myocardial infarction;
Contraindication to MRI.
University Health Network, Toronto
Lead sponsor
Vancouver General Hospital
Collaborator
The Cleveland Clinic
Collaborator
Icahn School of Medicine at Mount Sinai
Collaborator
IRCCS Policlinico S. Donato
Collaborator
Alberta Health services
Collaborator
Libin Cardiovascular Institute of Alberta
Collaborator
Vancouver Coastal Health
Collaborator